KEGG: bte:BTH_I2138
Recombinant BTH_I2138 is typically expressed in E. coli expression systems following these methodological steps:
Cloning and Vector Construction:
The BTH_I2138 gene (full-length 1-176 aa) is amplified from B. thailandensis genomic DNA
The gene is cloned into an expression vector (commonly pET-28a) with an N-terminal His-tag fusion
Sequence verification confirms correct insertion and orientation
Expression Conditions:
Transformation into E. coli BL21(DE3) strain
Culture growth at 37°C to mid-log phase
Induction with IPTG (typically 0.5-1.0 mM)
Post-induction growth at reduced temperature (16-25°C) for 4-18 hours
Purification Protocol:
Cell lysis by sonication in a Tris/PBS-based buffer
Affinity chromatography using His-Trap columns
Elution with imidazole gradient
Further purification by size-exclusion chromatography if needed
Storage Recommendations:
The typical purity achieved is greater than 90% as determined by SDS-PAGE analysis, making the protein suitable for various research applications.
BTH_I2138's structure directly relates to its function in bacterial cell division:
Membrane Topology:
The protein contains multiple transmembrane domains that anchor it within the inner bacterial membrane
Hydrophobic regions form alpha-helical transmembrane segments that span the lipid bilayer
Hydrophilic loops connect the transmembrane segments and may interact with cytoplasmic or periplasmic proteins
Functional Domains:
N-terminal region: Contains membrane-targeting sequences
Central region: Likely involved in protein-protein interactions with division machinery
C-terminal region: May participate in signaling or regulatory interactions
Structural Homology:
Similar structural features are found in YciB family proteins across bacterial species
Conserved motifs suggest common mechanistic functions in cell division
Predicted Role in Cell Division:
Localization to the division septum during cell division
Coordination with other division proteins to ensure proper septum formation
Potential role in recruiting or stabilizing divisome components
While a high-resolution structure has not yet been determined, computational models suggest a multi-pass membrane protein with domains extending into both the cytoplasm and periplasm .
Researchers can employ several complementary techniques to quantify BTH_I2138 expression:
Quantitative Real-Time PCR (qRT-PCR):
Principle: Measures BTH_I2138 mRNA levels using gene-specific primers
Protocol:
Extract total RNA from B. thailandensis cultures
Synthesize cDNA using reverse transcriptase
Perform qPCR with BTH_I2138-specific primers
Normalize to housekeeping genes (e.g., 16S rRNA)
Advantages: High sensitivity, quantitative, relatively simple
Limitations: Measures transcript but not protein levels
Western Blot Analysis:
Principle: Detects BTH_I2138 protein using specific antibodies
Protocol:
Prepare bacterial lysates from various growth conditions
Separate proteins by SDS-PAGE
Transfer to membrane and probe with anti-BTH_I2138 antibodies
Use isocitrate dehydrogenase (ICDH) as loading control
Advantages: Directly measures protein levels, can detect post-translational modifications
Limitations: Requires specific antibodies, semi-quantitative
Reporter Gene Fusions:
Principle: BTH_I2138 promoter drives expression of a reporter gene (GFP, luciferase)
Protocol:
Clone BTH_I2138 promoter upstream of reporter gene
Integrate construct into B. thailandensis genome
Measure reporter activity under various conditions
Advantages: Real-time monitoring, in vivo analysis
Limitations: Measures transcriptional activity, not protein levels
Mass Spectrometry-Based Proteomics:
Principle: Direct identification and quantification of BTH_I2138 peptides
Protocol:
Extract proteins from B. thailandensis
Digest with trypsin and analyze by LC-MS/MS
Quantify BTH_I2138-specific peptides
Advantages: Highly specific, can be quantitative, no antibodies needed
Limitations: Complex methodology, expensive equipment
This multi-technique approach allows researchers to comprehensively analyze BTH_I2138 expression at both transcriptional and translational levels, providing insights into its regulation during different growth phases or environmental conditions .
To rigorously investigate BTH_I2138's role in cell division, researchers should implement systematic experimental designs that establish causal relationships:
These experimental designs should incorporate proper controls, randomization, and blinding to minimize bias. Research by the PLOS One study found that "only 12% of all 271 studies in the sample" reported random allocation, and even fewer (9%) provided details of the randomization method , highlighting the importance of methodological rigor.
Single-case experimental designs (SCEDs) offer powerful approaches for studying BTH_I2138 function by enabling detailed analysis of temporal relationships and causal mechanisms:
ABAB Reversal Design Application:
| Phase | Condition | Measurement |
|---|---|---|
| A₁ (Baseline) | Wild-type BTH_I2138 expression | Cell division rate, septum formation |
| B₁ (Intervention) | Conditional BTH_I2138 depletion | Cell division rate, septum formation |
| A₂ (Return to baseline) | Restoration of BTH_I2138 expression | Cell division rate, septum formation |
| B₂ (Reintroduction) | Second depletion of BTH_I2138 | Cell division rate, septum formation |
This design provides "three replications of treatment effects (A₁ versus B₁, B₁ versus A₂, A₂ versus B₂)," establishing experimental control and demonstrating causality .
Multiple Baseline Design:
Create three bacterial cultures from the same parent culture
Introduce BTH_I2138 depletion at different time points for each culture
Monitor cell division parameters continuously across all cultures
Stagger intervention timing to control for time-dependent effects
Changing Criterion Design:
Use a titratable expression system for BTH_I2138
Gradually reduce expression levels at predetermined intervals
Measure corresponding changes in cell division parameters
Establish dose-response relationship between BTH_I2138 levels and function
Combined Designs:
"Combined reversal and multiple baseline designs... focus on demonstrating experimental control of the relationship between treatment and outcome" . This approach would involve multiple bacterial cultures subjected to different sequences of BTH_I2138 modulation.
SCEDs are particularly valuable for BTH_I2138 research as they allow for precise control of experimental conditions and detailed temporal analysis of phenotypic changes, with each bacterial culture serving as its own control. These designs can "be adapted for personalized medicine" approaches and provide robust "demonstration of treatment effects" .
Expressing recombinant full-length BTH_I2138 presents several technical challenges that require specific strategies:
Expression Challenges and Solutions:
Protein Structure Analysis:
"To ensure the acquisition of full-length proteins... increasing the imidazole concentration at elution" can help separate full-length protein from truncated forms. Additionally, "to solve these problems, researchers need to analyze the protein sequence and secondary structure, and adopt corresponding strategies to optimize the expression conditions" .
Purification Optimization:
Two-step purification approach: IMAC followed by size exclusion chromatography
Addition of glycerol (5-10%) to all buffers to enhance stability
Use of protease inhibitors to prevent degradation
Careful pH optimization (typically pH 7.5-8.5)
Stabilization Strategies:
By systematically addressing these challenges, researchers can achieve expression of functional, full-length BTH_I2138 suitable for structural and functional studies. The methods developed for BTH_I2138 can also serve as a model for expression of other challenging membrane proteins from Burkholderia species.
Understanding how BTH_I2138 expression varies across growth phases provides insights into its regulatory mechanisms and functional significance:
Expression Pattern Analysis:
Based on recent transcriptome-proteome profiling in B. thailandensis during transition to stationary phase, we can infer potential BTH_I2138 expression patterns:
| Growth Phase | Expected BTH_I2138 mRNA Level | Expected BTH_I2138 Protein Level | Biological Significance |
|---|---|---|---|
| Early exponential | Moderate-high | Moderate | Active cell division phase |
| Mid-exponential | High | High | Peak division activity |
| Late exponential | Decreasing | Sustained | Preparation for stationary phase |
| Early stationary | Low | Moderate | Reduced division activity |
| Late stationary | Very low | Low | Minimal division |
This pattern would align with the observation that "proteins related to fatty acid degradation and butanoate metabolism accumulated along with proteins involved in synthesis of secondary metabolites" while "ribosomal proteins as well as the house-keeping iron-sulfur biogenesis proteins" were downregulated during stationary phase .
Methodological Approach:
To specifically study BTH_I2138 expression:
Collect samples at defined time points (OD600 = 0.2, 0.5, 1.0, 1.5, 2.0)
Extract RNA for qRT-PCR analysis of BTH_I2138 transcripts
Prepare protein samples for Western blot with anti-BTH_I2138 antibodies
Use RNA-Seq and proteomics for global expression context
Regulatory Mechanisms:
"An only modest correlation between transcriptome and proteome changes was seen, and the RpoS sigma factor was not significantly increased during early stationary phase" , suggesting that BTH_I2138 might be subject to complex post-transcriptional regulation.
Integration with Global Expression Data:
The study identified "928 differentially expressed genes and 832 differentially expressed proteins" during stationary phase entry, providing context for understanding BTH_I2138 regulation within the broader cellular adaptation processes.
The potential connection between BTH_I2138 and c-di-GMP signaling represents an intriguing research direction that could reveal novel regulatory mechanisms:
Background on c-di-GMP Signaling in B. thailandensis:
"As a key bacterial second messenger, cyclic di-GMP (c-di-GMP) regulates various physiological processes, such as motility, biofilm formation, and virulence. Cellular c-di-GMP levels are regulated by the opposing activities of diguanylate cyclases (DGCs) and phosphodiesterases (PDEs)" .
Hypothetical Connections and Experimental Approaches:
| Hypothesis | Experimental Approach | Expected Outcome if Positive |
|---|---|---|
| BTH_I2138 is regulated by c-di-GMP | Monitor BTH_I2138 expression in ΔpdcA, ΔpdcB, and ΔpdcC mutants | Altered BTH_I2138 levels in mutants compared to wild-type |
| BTH_I2138 affects c-di-GMP levels | Measure c-di-GMP in ΔBTH_I2138 mutant | Changed c-di-GMP concentration in mutant |
| BTH_I2138 interacts with c-di-GMP pathway components | Co-immunoprecipitation with PdcA, PdcB, or PdcC | Detection of protein-protein interactions |
| BTH_I2138 mutation affects c-di-GMP-regulated phenotypes | Assess biofilm formation and motility in ΔBTH_I2138 | Altered phenotypes similar to c-di-GMP pathway mutants |
Methodological Details:
Co-immunoprecipitation: "Co-IP studies using TSHR (left panel) or CD40 antibodies (right panel) show that TSHR antibody pulls down TSHR and CD40, and CD40 antibody also pulls down both proteins, indicating physical contact between the 2 proteins"
Bacterial two-hybrid system: "The bacterial hybrid plasmids pKT25M-pas, pKT25M-ggdef, pKT25M-pdcB, pUT18CM-pdcB, and pUT18CM-pdcC were constructed" - similar approach could be applied to BTH_I2138
Potential Biological Significance:
"The observation that homologous operons of pdcABC are widespread among betaproteobacteria and gammaproteobacteria suggests a general mechanism by which the intracellular concentration of c-di-GMP is modulated to coordinate bacterial behavior and virulence" . If BTH_I2138 interacts with this pathway, it would reveal a novel link between cell division and other bacterial behaviors regulated by c-di-GMP.
Investigating these potential connections could uncover previously unknown mechanisms coordinating cell division with biofilm formation, motility, and virulence in Burkholderia species, potentially revealing new targets for antimicrobial development.
B. thailandensis provides an excellent BSL-1 model system for studying virulence mechanisms relevant to the highly pathogenic B. pseudomallei:
Advantages of B. thailandensis as a Model:
"B. thailandensis could be utilized as an attractive model system to facilitate the study of the role of the Bsa TTSS during Burkholderia infection, since, in contrast to the mandated B. pseudomallei working conditions, work with B. thailandensis does not require a biosafety level 3 (BSL-3) containment facility and there is no restriction on the use of antibiotic-resistance markers for its genetic manipulation" .
Experimental Strategy for Assessing BTH_I2138's Role in Virulence:
T3SS Assay Details:
"Deletion of pdcA or pdcB resulted in significantly increased secretion of BipD and deletion of pdcC leads to significantly reduced secretion of BipD compared with the wild-type strain... The expression of pdcA or pdcC in the corresponding mutant restored the secretion of BipD to wild-type levels" . Similar approaches could be used to assess if BTH_I2138 affects T3SS function.
Translation to B. pseudomallei:
Sequence comparison of BTH_I2138 with B. pseudomallei homolog
Conservation analysis of potential interaction partners
Validation of key findings in B. pseudomallei (if BSL-3 facilities available)
This systematic approach leverages the advantages of B. thailandensis while generating data relevant to understanding virulence mechanisms in the more pathogenic B. pseudomallei, potentially revealing new aspects of how cell division proteins like BTH_I2138 may influence bacterial pathogenesis.
Investigating protein-protein interactions is crucial for understanding BTH_I2138's role in cell division networks:
Co-immunoprecipitation (Co-IP):
Methodology: "Co-IP studies using TSHR (left panel) or CD40 antibodies (right panel) show that TSHR antibody pulls down TSHR and CD40, and CD40 antibody also pulls down both proteins, indicating physical contact between the 2 proteins"
Application to BTH_I2138: Generate specific antibodies against BTH_I2138, perform immunoprecipitation, and identify co-precipitated proteins by mass spectrometry
Advantages: Detects native interactions in cellular context
Challenges: Requires specific antibodies, membrane protein solubilization issues
Bacterial Two-Hybrid System:
Methodology: "The bacterial hybrid plasmids pKT25M-pas, pKT25M-ggdef, pKT25M-pdcB, pUT18CM-pdcB, and pUT18CM-pdcC were constructed in similar manners by using the primers listed in Table 2"
Application to BTH_I2138: Create fusion constructs with BTH_I2138 and potential interacting partners
Advantages: Specifically designed for bacterial proteins, works well for membrane proteins
Challenges: May detect non-physiological interactions
Proximity-Dependent Biotin Identification (BioID):
| Step | Procedure | Technical Considerations |
|---|---|---|
| 1 | Create fusion of BTH_I2138 with BirA* biotin ligase | Confirm functionality of fusion protein |
| 2 | Express in B. thailandensis | Optimize expression level |
| 3 | Add biotin to growth medium | Typically 50 μM biotin for 24h |
| 4 | Lyse cells and purify biotinylated proteins | Use stringent washing conditions |
| 5 | Identify biotinylated proteins by mass spectrometry | Compare to control samples |
Advantages: Detects transient interactions, works in native cellular environment
Challenges: May identify proteins in proximity but not directly interacting
Förster Resonance Energy Transfer (FRET):
Methodology: Create fluorescent protein fusions to BTH_I2138 and candidate partners
Application: Express in B. thailandensis and measure energy transfer between fluorophores
Advantages: Can detect interactions in live cells
Challenges: Requires careful control experiments, potential interference of fluorescent tags
Cross-linking Mass Spectrometry:
Methodology: Treat cells with cross-linking reagents, purify BTH_I2138, digest, and identify cross-linked peptides
Advantages: Can capture transient interactions, identifies specific interaction sites
Challenges: Complex data analysis, requires high-resolution mass spectrometry
These complementary approaches provide a comprehensive strategy for mapping BTH_I2138's protein interaction network, revealing its role in cell division and potentially uncovering connections to other cellular processes such as virulence or stress response.
Systematic characterization of BTH_I2138 mutations provides critical insights into structure-function relationships:
Mutation Strategy and Analysis:
| Mutation Type | Design Approach | Analysis Method | Expected Phenotype |
|---|---|---|---|
| Complete deletion | Allelic exchange | Phase contrast microscopy | Potential filamentous growth or division defects |
| Conserved residue substitutions | Site-directed mutagenesis | Time-lapse microscopy | Varied severity based on residue importance |
| Domain deletions | In-frame deletions | Electron microscopy | Domain-specific functional defects |
| C-terminal/N-terminal truncations | Premature stop codons | Fluorescent microscopy with membrane stains | Insights into terminal region functions |
Microscopy Analysis Protocol:
Fix bacterial cells with 4% paraformaldehyde
Stain membranes with FM4-64 (red) and DNA with DAPI (blue)
Image using confocal microscopy
Quantify cell length, width, and nucleoid positioning
Perform statistical analysis comparing mutants to wild-type
Morphological Parameters to Measure:
| Parameter | Measurement Method | Significance |
|---|---|---|
| Cell length | Phase contrast imaging with automated cell detection | Indicates division frequency |
| Cell width | Phase contrast imaging with automated cell detection | Reflects cell wall synthesis |
| Septum positioning | Membrane staining | Shows division site selection accuracy |
| Nucleoid segregation | DNA staining | Reveals chromosome partitioning |
| Z-ring formation | FtsZ-GFP fusion imaging | Indicates divisome assembly |
Experimental Controls:
Include wild-type strain in all experiments
Create complemented strains expressing wild-type BTH_I2138
Use appropriate statistical methods with biological replicates
This approach follows experimental design principles noted in search result : "A good experimental design requires a strong understanding of the system you are studying" and incorporates the recommendation to "systematically and precisely manipulate the independent variable(s)" while "precisely measuring the dependent variable(s)" .
The resulting data would provide detailed insights into how specific regions or residues of BTH_I2138 contribute to proper cell division in B. thailandensis, potentially revealing conserved mechanisms across bacterial species.
Integrating transcriptomic and proteomic data provides a comprehensive view of BTH_I2138's function in cellular context:
Experimental Design Considerations:
| Design Element | Recommendation | Rationale |
|---|---|---|
| Comparison groups | Wild-type vs. ΔBTH_I2138 mutant | Direct assessment of BTH_I2138's impact |
| Growth conditions | Multiple conditions (e.g., rich media, minimal media, stress) | Reveals condition-specific effects |
| Time points | Multiple points during growth curve | Captures dynamic regulation |
| Replication | Minimum 3 biological replicates | Ensures statistical robustness |
| Controls | Include complemented strain | Confirms phenotypes are due to BTH_I2138 |
Technical Approach:
Transcriptomics: "RNA sequencing (RNA-Seq) to identify differentially expressed genes"
Proteomics: "Mass spectrometry-based quantitative proteomics (e.g., iTRAQ, TMT, SILAC)"
Integration: "Correlation analysis between transcript and protein levels"
Expected Outcomes and Interpretation:
Based on previous B. thailandensis studies: "We identified 928 differentially expressed genes and 832 differentially expressed proteins" and "an only modest correlation between transcriptome and proteome changes was seen" . This suggests that:
Post-transcriptional regulation may be important for BTH_I2138 function
Protein-level changes may not always reflect transcript-level changes
Integrated analysis is essential for complete understanding
Validation Approaches:
qRT-PCR for selected differentially expressed genes
Western blot for key protein changes
Phenotypic analysis of mutants in identified pathways
Protein-protein interaction studies for potential BTH_I2138 partners
This integrated approach aligns with modern systems biology practices and provides a more complete picture of BTH_I2138's role than either transcriptomics or proteomics alone, potentially revealing unexpected connections to other cellular processes and regulatory networks.
Developing high-quality antibodies against BTH_I2138 is essential for many experimental applications:
Antigen Design Strategy:
| Antigen Type | Advantages | Disadvantages | Design Considerations |
|---|---|---|---|
| Full-length recombinant BTH_I2138 | Complete epitope representation | Challenging expression, hydrophobicity | Use His-tag for purification, solubilize with appropriate detergents |
| Synthetic peptides from hydrophilic regions | Easier production, target specific domains | Limited epitopes, may not recognize native protein | Select 15-20aa peptides from predicted extracellular loops |
| Extracellular domain fragments | Balance between specificity and native structure | Expression challenges | Careful boundary selection to ensure proper folding |
Immunization Protocol Based on BipD Antibody Development:
"The rBipD was obtained by affinity chromatography using His Trap column, then mixed with Fredrick's adjuvant to immunize BALB/c mice by intraperitoneal injection in order to obtain anti-rBipD polyclonal antibodies" . The protocol yielded high-titer antibodies (1:512,000).
Adapted Protocol for BTH_I2138:
Purify recombinant His-tagged BTH_I2138 protein
Mix with Freund's complete adjuvant for initial immunization
Boost with antigen in Freund's incomplete adjuvant at days 14, 28, and 42
Collect serum and test antibody titer by ELISA
Purify IgG fraction using protein A/G columns
Validation Strategy:
| Validation Test | Methodology | Acceptance Criteria |
|---|---|---|
| Western blot against recombinant BTH_I2138 | Standard Western blot protocol | Single band at expected MW (~20 kDa plus tag) |
| Western blot against B. thailandensis lysates | Compare wild-type and ΔBTH_I2138 strains | Band present in wild-type, absent in knockout |
| Immunofluorescence microscopy | Fixed B. thailandensis cells | Specific membrane localization pattern |
| Cross-reactivity testing | Western blot against related Burkholderia species | Expected bands in species with homologous proteins |
| Pre-immune serum control | All applications | No specific reactivity |
Application Optimization:
For Western blot: Determine optimal antibody dilution, blocking conditions
For immunoprecipitation: Test different lysis buffers, antibody amounts
For immunofluorescence: Optimize fixation method, permeabilization conditions
For ELISA: Establish standard curves, determine detection limits
Following these methodological steps will yield high-quality antibodies against BTH_I2138 that can be used to investigate its expression, localization, and interactions, significantly advancing research on this important cell division protein.